An in vivo microdialysis study of striatal 6-[18F]fluoro-L-m-tyrosine metabolism

Neurochemical Research

Volumn 23, Issue 4, 1998, Pages 513-517

  Jordan, Shaun ^a,b   Bankiewicz, Krzysztof S ^c   Eberling, Jamie L ^a   VanBrocklin, Henry F ^a   O'Neil, James P ^a   Jagust, William J ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PFIZER INC   (United States)

^c CELL GENESYS INC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

6 18 fluro L m tyrosine; Amphetamine; Metabolism; Microdialysis; PET; Striatum

Indexed keywords

TYROSINE;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ARTICLE; BRAIN METABOLISM; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; MALE; MEMBRANE VESICLE; MICRODIALYSIS; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT;

ANIMALS; BIOLOGICAL TRANSPORT; BIOTRANSFORMATION; CORPUS STRIATUM; DEXTROAMPHETAMINE; FLUORINE RADIOISOTOPES; KINETICS; MALE; MICRODIALYSIS; PHENYLACETATES; RATS; RATS, WISTAR; RESERPINE; TIME FACTORS; TYROSINE;

ANIMALIA;

EID: 0031967367     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022478417383     Document Type: Article

References (21)

1. 18F]6-fluoro-L-m-tyrosine in the human brain. Movement Disorders 10:298-304.
2. 18F]Fluoro-L-m-tyrosine: an L-3,4-dihydroxyphenylalanine analog for probing presynaptic dopaminergic function with positron emission tomography. J. Neurochem. 53:311-314.
3. 18F]fluoro-L-m-tyrosine in MPTP-induced hemiparkinsonian monkeys. Ann. Nuclear. Med. 9:119-23.
4. 18F]fluoro-L-m-tyrosine: metabolism and positron emission tomography kinetics, and 1-methyl-4-phenyly-1,2,3,6-tetrahydropyridine lesions in primates. Brain. Res. 750:264-276.
5. Barrio, J., Huang, S-C., Yu, D-C., Melega, W. P., Quintana, J., Cherry, S. R., Jacobson, A., Namavari, M., Satyamurthy, N., and Phelps, M. E. 1996. Radiofluorinated L-m-tyrosines: new in-vivo probes for central dopamine biochemistry. J. Cereb. Blood Flow Metab. 16:667-668.
6. 18F]-fluorodopamine and analogs. J. Cereb. Blood Flow Metab. 15:LVIII-15.
7. Endres, C., Swaminathan, S., Ruoho, A. E., Sievert, M., DeJesus, O. T., Murali, D., and Holden, J. E. 1995. Uptake mechanisms of PET DOPA analogs: amine affinities for monoamine granular and plasma membrane translocators. J. Cereb. Blood Flow Metab. 15: LVIII-16.
8. Segal, M. B., and Zlokovic, B. V. 1990. Amino acids and the blood-brain barrier. Pages 31-46, in, The blood brain barrier, amino acids and peptides, Kluwer Publishers, Boston.
9. Cadoni, C., Pinna, A., Russi, G., Consolo, S., and Di Chiara, G. 1995. Role of vesicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: evidence from microdialysis and fos immunohistochemistry. Neurosci. 65:1027-1039.
10. Heeringa, M., and Abercrombie, E. D. 1995. Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release. J. Neurochem. 65:192-200.
11. Paxinos, G., and Watson, C. 1986. The rat brain in stereotaxic coordinates. Academic Press, San Diego.
12. Kirshner, N. 1962. Uptake of catecholamines by a particulate fraction of the adrenal medulla. J. Biol. Chem. 237:2311-2317.
13. Lechardeur, D., Castel, M. N., Reibaud, M., Scherman, D., and Laduron, P. M. 1993. Axonal transport of dopamine-containing vesicles labelled in vivo with [3H]reserpine. Brain Res. 499:205-213.
14. Demarest, K., Smith, D. J., and Azzaro, A. J. 1980. The presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons. J. Pharmacol. Exper. Therap. 215: 461-468.
15. Seiden, L., Sabol, K. E., and Ricaurte, G. A. 1993. Amphetamine: effects on catecholamine systems and behavior. Brain Res. Bull. 31:305-310.
16. Fischer, F., and Cho, A. K. 1979. Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J. Pharmacol. Exp. Ther. 208:203-209.
17. Ereckinska, M., Pastuszko, A., Wilson, D. F., and Nelson, D. 1987. Ammonia-induced release of neurotransmitters from rat brain synaptosomes: differences between the effects of amines and amino acids. J. Neurochem. 49:1258-1265.
18. Sulzer, D., and Rayport, S. 1990. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron 5: 797-808.
19. Gonzalez, A., Walther, D., Pazos, A., and Uhl, G. R. 1994. Synaptic vesicular monoamine transporter expression: distribution and pharmacologic profile. Mol. Brain Res. 22:219-226.
20. Schuldiner, S., Steiner-Mordoch, S., Yelin, R., Wall, S. C., and Rudnick, G. 1993. Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine trans-porters. Mol. Pharmacol. 44:1227-1231.
21. Vaccari, A. 1993. The tyramine binding site in the central nervous system: an overview. 18:861-868.